The latest Materiovigilance Programme of India (MvPI) E-Newsletter – Volume 8, Issue 2 (2026) provides valuable updates on medical device safety, adverse event reporting and ongoing Materiovigilance activities across India.
This issue covers newly approved Medical Device Adverse Event Monitoring Centers (MDMCs), training and educational initiatives, MvPI activities and expert sessions, safety alerts, recommendations to the Central Drugs Standard Control Organisation (CDSCO), reporting modalities, the MvPI network across India, and upcoming workshops and training programmes.
The newsletter also highlights efforts to strengthen Medical Device Adverse Event (MDAE) reporting, including practical approaches to reporting through ADRMS and capacity-building initiatives for healthcare professionals and other stakeholders.
Of particular interest for pharmaceutical, medical-device, QA, regulatory and healthcare professionals are the recommendations made to CDSCO concerning issues associated with devices such as IV cannulas, single-use syringes, syringe pumps and intravenous infusion sets.
The newsletter is a useful reference for professionals looking to stay informed about developments in medical device safety, materiovigilance, adverse event reporting and regulatory initiatives in India.
Source: National Coordination Centre – Materiovigilance Programme of India, Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Government of India.
